Cabergoline, a long-acting dopamine D2-like receptor agonist, produces a sustained antiparkinsonian effect with transient dyskinesias in parkinsonian drug-naive primates
Research output: Contribution to journal › Article › peer-review
55Scopus
citations
Fingerprint
Dive into the research topics of 'Cabergoline, a long-acting dopamine D2-like receptor agonist, produces a sustained antiparkinsonian effect with transient dyskinesias in parkinsonian drug-naive primates'. Together they form a unique fingerprint.